not only is there a need for Neudexta, there are other indications being tested (ie. for Diabetic Neuropathy)... Only the shorts and manipulators of this stock would have you believe that the people at Avanir went thru this long process blindly, this company will succeed... and hopefully share holders will finally be rewarded
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.